Business Description
SynCore Biotechnology Co Ltd
ISIN : TW0004192000
Description
SynCore Biotechnology Co Ltd is a Biotechnology company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from Healthy food sales.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.07 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.55 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 39.52 | |||||
| Beneish M-Score | 2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.1 | |||||
| 3-Year EBITDA Growth Rate | 64.1 | |||||
| 3-Year EPS without NRI Growth Rate | 56.1 | |||||
| 3-Year FCF Growth Rate | 39 | |||||
| 3-Year Book Growth Rate | -19.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.43 | |||||
| 9-Day RSI | 29.16 | |||||
| 14-Day RSI | 32.91 | |||||
| 6-1 Month Momentum % | -17.28 | |||||
| 12-1 Month Momentum % | 0.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.3 | |||||
| Quick Ratio | 14.86 | |||||
| Cash Ratio | 12.52 | |||||
| Days Inventory | 140.89 | |||||
| Days Sales Outstanding | 37.41 | |||||
| Days Payable | 56.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.7 | |||||
| Shareholder Yield % | 3.39 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7.75 | |||||
| Operating Margin % | -44.27 | |||||
| Net Margin % | 1.59 | |||||
| FCF Margin % | -335.83 | |||||
| ROE % | 0.12 | |||||
| ROA % | 0.11 | |||||
| ROIC % | -10.25 | |||||
| ROC (Joel Greenblatt) % | 1.68 | |||||
| ROCE % | 0.2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2492.71 | |||||
| PE Ratio without NRI | 2492.71 | |||||
| PEG Ratio | 60.5 | |||||
| PS Ratio | 54.02 | |||||
| PB Ratio | 3.93 | |||||
| Price-to-Tangible-Book | 4.6 | |||||
| EV-to-EBIT | 1669.32 | |||||
| EV-to-EBITDA | 54.05 | |||||
| EV-to-Revenue | 44.41 | |||||
| EV-to-FCF | -13.93 | |||||
| Price-to-Median-PS-Value | 0.22 | |||||
| Price-to-Graham-Number | 22.63 | |||||
| Price-to-Net-Current-Asset-Value | 4.99 | |||||
| Price-to-Net-Cash | 6.2 | |||||
| Earnings Yield (Greenblatt) % | 0.06 | |||||
| FCF Yield % | -6.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SynCore Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 22.93 | ||
| EPS (TTM) (NT$) | 0.014 | ||
| Beta | 0.48 | ||
| Volatility % | 34.26 | ||
| 14-Day RSI | 32.91 | ||
| 14-Day ATR (NT$) | 0.631383 | ||
| 20-Day SMA (NT$) | 36.8625 | ||
| 12-1 Month Momentum % | 0.41 | ||
| 52-Week Range (NT$) | 34.55 - 57.8 | ||
| Shares Outstanding (Mil) | 35.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SynCore Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SynCore Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
SynCore Biotechnology Co Ltd Frequently Asked Questions
What is SynCore Biotechnology Co Ltd(ROCO:4192)'s stock price today?
The current price of ROCO:4192 is NT$34.85. The 52 week high of ROCO:4192 is NT$57.80 and 52 week low is NT$34.55.
When is next earnings date of SynCore Biotechnology Co Ltd(ROCO:4192)?
The next earnings date of SynCore Biotechnology Co Ltd(ROCO:4192) is .
Does SynCore Biotechnology Co Ltd(ROCO:4192) pay dividends? If so, how much?
SynCore Biotechnology Co Ltd(ROCO:4192) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers